Cargando…
Complete reversibility of pembrolizumab-induced eosinophilic fasciitis without corticosteroids: A case report
Checkpoint inhibitor immunotherapy has recently started to play a fundamental role in the management of metastatic melanoma. It is however accountable for many undesirable adverse effects involving many organ systems. Eosinophilic fasciitis is a rare immune-related adverse effect associated to check...
Autores principales: | Bourcier, Liane, St-Hilaire, Ève, LeBlanc, Martin, Picard, Léo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202265/ https://www.ncbi.nlm.nih.gov/pubmed/34178352 http://dx.doi.org/10.1177/2050313X211025111 |
Ejemplares similares
-
Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab
por: Zampeli, Evangelia, et al.
Publicado: (2021) -
Eosinophilic fasciitis
por: Lamback, Elisa Baranski, et al.
Publicado: (2016) -
Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on (18)F-FDG-PET/CT
por: Amrane, Karim, et al.
Publicado: (2022) -
84. Eosinophilic fasciitis
por: Golla, Janardhana, et al.
Publicado: (2018) -
Not just eosinophilic fasciitis
por: Chirila, Razvan, et al.
Publicado: (2021)